Global Cell and Advanced Therapies Supply Chain Management Market Research Report 2023

The global Cell and Advanced Therapies Supply Chain Management market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Cell and Advanced Therapies Supply Chain Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Cell and Advanced Therapies Supply Chain Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Cell and Advanced Therapies Supply Chain Management in Biobank is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Cell and Advanced Therapies Supply Chain Management include Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM and MasterControl, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell and Advanced Therapies Supply Chain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Advanced Therapies Supply Chain Management.

The Cell and Advanced Therapies Supply Chain Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell and Advanced Therapies Supply Chain Management market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell and Advanced Therapies Supply Chain Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cloud

1.2.3 On-premises

1.3 Market by Application

1.3.1 Global Cell and Advanced Therapies Supply Chain Management Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Biobank

1.3.3 Cell Therapy Lab

1.3.4 Hospital

1.3.5 Research Institute

1.3.6 Commercial Organization

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Cell and Advanced Therapies Supply Chain Management Market Perspective (2018-2029)

2.2 Cell and Advanced Therapies Supply Chain Management Growth Trends by Region

2.2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Cell and Advanced Therapies Supply Chain Management Historic Market Size by Region (2018-2023)

2.2.3 Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Region (2024-2029)

2.3 Cell and Advanced Therapies Supply Chain Management Market Dynamics

2.3.1 Cell and Advanced Therapies Supply Chain Management Industry Trends

2.3.2 Cell and Advanced Therapies Supply Chain Management Market Drivers

2.3.3 Cell and Advanced Therapies Supply Chain Management Market Challenges

2.3.4 Cell and Advanced Therapies Supply Chain Management Market Restraints

3.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue

3.1.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue (2018-2023)

3.1.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Players (2018-2023)

3.2 Global Cell and Advanced Therapies Supply Chain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell and Advanced Therapies Supply Chain Management Revenue

3.4 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio

3.4.1 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell and Advanced Therapies Supply Chain Management Revenue in 2022

3.5 Cell and Advanced Therapies Supply Chain Management Key Players Head office and Area Served

3.6 Key Players Cell and Advanced Therapies Supply Chain Management Product Solution and Service

3.7 Date of Enter into Cell and Advanced Therapies Supply Chain Management Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Type (2018-2023)

4.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2024-2029)

5.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Application (2018-2023)

5.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2024-2029)

6.1 North America Cell and Advanced Therapies Supply Chain Management Market Size (2018-2029)

6.2 North America Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023)

6.4 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size (2018-2029)

7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023)

7.4 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size (2018-2029)

8.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2018-2023)

8.4 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size (2018-2029)

9.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023)

9.4 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size (2018-2029)

10.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023)

10.4 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Be The Match BioTherapies

11.1.1 Be The Match BioTherapies Company Detail

11.1.2 Be The Match BioTherapies Business Overview

11.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Introduction

11.1.4 Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.1.5 Be The Match BioTherapies Recent Development

11.2 Brooks Life Sciences

11.2.1 Brooks Life Sciences Company Detail

11.2.2 Brooks Life Sciences Business Overview

11.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Introduction

11.2.4 Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.2.5 Brooks Life Sciences Recent Development

11.3 Clarkston Consulting

11.3.1 Clarkston Consulting Company Detail

11.3.2 Clarkston Consulting Business Overview

11.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Introduction

11.3.4 Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.3.5 Clarkston Consulting Recent Development

11.4 Cryoport

11.4.1 Cryoport Company Detail

11.4.2 Cryoport Business Overview

11.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Introduction

11.4.4 Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.4.5 Cryoport Recent Development

11.5 Haemonetics

11.5.1 Haemonetics Company Detail

11.5.2 Haemonetics Business Overview

11.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Introduction

11.5.4 Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.5.5 Haemonetics Recent Development

11.6 Hypertrust Patient Data Care

11.6.1 Hypertrust Patient Data Care Company Detail

11.6.2 Hypertrust Patient Data Care Business Overview

11.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Introduction

11.6.4 Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.6.5 Hypertrust Patient Data Care Recent Development

11.7 Lykan Bioscience

11.7.1 Lykan Bioscience Company Detail

11.7.2 Lykan Bioscience Business Overview

11.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Introduction

11.7.4 Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.7.5 Lykan Bioscience Recent Development

11.8 MAK-SYSTEM

11.8.1 MAK-SYSTEM Company Detail

11.8.2 MAK-SYSTEM Business Overview

11.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Introduction

11.8.4 MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.8.5 MAK-SYSTEM Recent Development

11.9 MasterControl

11.9.1 MasterControl Company Detail

11.9.2 MasterControl Business Overview

11.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Introduction

11.9.4 MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.9.5 MasterControl Recent Development

11.10 SAP

11.10.1 SAP Company Detail

11.10.2 SAP Business Overview

11.10.3 SAP Cell and Advanced Therapies Supply Chain Management Introduction

11.10.4 SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.10.5 SAP Recent Development

11.11 SAVSU Technologies

11.11.1 SAVSU Technologies Company Detail

11.11.2 SAVSU Technologies Business Overview

11.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Introduction

11.11.4 SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.11.5 SAVSU Technologies Recent Development

11.12 sedApta Group

11.12.1 sedApta Group Company Detail

11.12.2 sedApta Group Business Overview

11.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Introduction

11.12.4 sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.12.5 sedApta Group Recent Development

11.13 Stafa Cellular Therapy

11.13.1 Stafa Cellular Therapy Company Detail

11.13.2 Stafa Cellular Therapy Business Overview

11.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Introduction

11.13.4 Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.13.5 Stafa Cellular Therapy Recent Development

11.14 Title21 Health Solutions

11.14.1 Title21 Health Solutions Company Detail

11.14.2 Title21 Health Solutions Business Overview

11.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Introduction

11.14.4 Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.14.5 Title21 Health Solutions Recent Development

11.15 TraceLink

11.15.1 TraceLink Company Detail

11.15.2 TraceLink Business Overview

11.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Introduction

11.15.4 TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.15.5 TraceLink Recent Development

11.16 TrakCel

11.16.1 TrakCel Company Detail

11.16.2 TrakCel Business Overview

11.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Introduction

11.16.4 TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.16.5 TrakCel Recent Development

11.17 Vineti

11.17.1 Vineti Company Detail

11.17.2 Vineti Business Overview

11.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Introduction

11.17.4 Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

11.17.5 Vineti Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cloud

    Table 3. Key Players of On-premises

    Table 4. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Cell and Advanced Therapies Supply Chain Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Cell and Advanced Therapies Supply Chain Management Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region (2018-2023)

    Table 8. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region (2024-2029)

    Table 10. Cell and Advanced Therapies Supply Chain Management Market Trends

    Table 11. Cell and Advanced Therapies Supply Chain Management Market Drivers

    Table 12. Cell and Advanced Therapies Supply Chain Management Market Challenges

    Table 13. Cell and Advanced Therapies Supply Chain Management Market Restraints

    Table 14. Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players (2018-2023)

    Table 16. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2022)

    Table 17. Ranking of Global Top Cell and Advanced Therapies Supply Chain Management Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Cell and Advanced Therapies Supply Chain Management Product Solution and Service

    Table 21. Date of Enter into Cell and Advanced Therapies Supply Chain Management Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Cell and Advanced Therapies Supply Chain Management Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2018-2023)

    Table 25. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2024-2029)

    Table 27. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2018-2023)

    Table 29. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2024-2029)

    Table 31. North America Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Be The Match BioTherapies Company Detail

    Table 47. Be The Match BioTherapies Business Overview

    Table 48. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product

    Table 49. Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 50. Be The Match BioTherapies Recent Development

    Table 51. Brooks Life Sciences Company Detail

    Table 52. Brooks Life Sciences Business Overview

    Table 53. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product

    Table 54. Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 55. Brooks Life Sciences Recent Development

    Table 56. Clarkston Consulting Company Detail

    Table 57. Clarkston Consulting Business Overview

    Table 58. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product

    Table 59. Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 60. Clarkston Consulting Recent Development

    Table 61. Cryoport Company Detail

    Table 62. Cryoport Business Overview

    Table 63. Cryoport Cell and Advanced Therapies Supply Chain Management Product

    Table 64. Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 65. Cryoport Recent Development

    Table 66. Haemonetics Company Detail

    Table 67. Haemonetics Business Overview

    Table 68. Haemonetics Cell and Advanced Therapies Supply Chain Management Product

    Table 69. Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 70. Haemonetics Recent Development

    Table 71. Hypertrust Patient Data Care Company Detail

    Table 72. Hypertrust Patient Data Care Business Overview

    Table 73. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product

    Table 74. Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 75. Hypertrust Patient Data Care Recent Development

    Table 76. Lykan Bioscience Company Detail

    Table 77. Lykan Bioscience Business Overview

    Table 78. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product

    Table 79. Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 80. Lykan Bioscience Recent Development

    Table 81. MAK-SYSTEM Company Detail

    Table 82. MAK-SYSTEM Business Overview

    Table 83. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product

    Table 84. MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 85. MAK-SYSTEM Recent Development

    Table 86. MasterControl Company Detail

    Table 87. MasterControl Business Overview

    Table 88. MasterControl Cell and Advanced Therapies Supply Chain Management Product

    Table 89. MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 90. MasterControl Recent Development

    Table 91. SAP Company Detail

    Table 92. SAP Business Overview

    Table 93. SAP Cell and Advanced Therapies Supply Chain Management Product

    Table 94. SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 95. SAP Recent Development

    Table 96. SAVSU Technologies Company Detail

    Table 97. SAVSU Technologies Business Overview

    Table 98. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product

    Table 99. SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 100. SAVSU Technologies Recent Development

    Table 101. sedApta Group Company Detail

    Table 102. sedApta Group Business Overview

    Table 103. sedApta Group Cell and Advanced Therapies Supply Chain Management Product

    Table 104. sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 105. sedApta Group Recent Development

    Table 106. Stafa Cellular Therapy Company Detail

    Table 107. Stafa Cellular Therapy Business Overview

    Table 108. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product

    Table 109. Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 110. Stafa Cellular Therapy Recent Development

    Table 111. Title21 Health Solutions Company Detail

    Table 112. Title21 Health Solutions Business Overview

    Table 113. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product

    Table 114. Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 115. Title21 Health Solutions Recent Development

    Table 116. TraceLink Company Detail

    Table 117. TraceLink Business Overview

    Table 118. TraceLink Cell and Advanced Therapies Supply Chain Management Product

    Table 119. TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 120. TraceLink Recent Development

    Table 121. TrakCel Company Detail

    Table 122. TrakCel Business Overview

    Table 123. TrakCel Cell and Advanced Therapies Supply Chain Management Product

    Table 124. TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 125. TrakCel Recent Development

    Table 126. Vineti Company Detail

    Table 127. Vineti Business Overview

    Table 128. Vineti Cell and Advanced Therapies Supply Chain Management Product

    Table 129. Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2018-2023) & (US$ Million)

    Table 130. Vineti Recent Development

    Table 131. Research Programs/Design for This Report

    Table 132. Key Data Information from Secondary Sources

    Table 133. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Cell and Advanced Therapies Supply Chain Management Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Cell and Advanced Therapies Supply Chain Management Market Share by Type: 2022 VS 2029

    Figure 3. Cloud Features

    Figure 4. On-premises Features

    Figure 5. Global Cell and Advanced Therapies Supply Chain Management Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Cell and Advanced Therapies Supply Chain Management Market Share by Application: 2022 VS 2029

    Figure 7. Biobank Case Studies

    Figure 8. Cell Therapy Lab Case Studies

    Figure 9. Hospital Case Studies

    Figure 10. Research Institute Case Studies

    Figure 11. Commercial Organization Case Studies

    Figure 12. Cell and Advanced Therapies Supply Chain Management Report Years Considered

    Figure 13. Global Cell and Advanced Therapies Supply Chain Management Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Cell and Advanced Therapies Supply Chain Management Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region: 2022 VS 2029

    Figure 16. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players in 2022

    Figure 17. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue in 2022

    Figure 19. North America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2018-2029)

    Figure 21. United States Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Cell and Advanced Therapies Supply Chain Management Market Share by Country (2018-2029)

    Figure 25. Germany Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Share by Region (2018-2029)

    Figure 33. China Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2018-2029)

    Figure 41. Mexico Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Share by Country (2018-2029)

    Figure 45. Turkey Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Be The Match BioTherapies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 48. Brooks Life Sciences Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 49. Clarkston Consulting Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 50. Cryoport Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 51. Haemonetics Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 52. Hypertrust Patient Data Care Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 53. Lykan Bioscience Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 54. MAK-SYSTEM Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 55. MasterControl Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 56. SAP Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 57. SAVSU Technologies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 58. sedApta Group Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 59. Stafa Cellular Therapy Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 60. Title21 Health Solutions Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 61. TraceLink Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 62. TrakCel Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 63. Vineti Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2018-2023)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed